🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07373717
Enrolling by invitation

Consistency of Fluid Tolerance Evaluation Methods and Their Correlation With Clinical Outcomes in Patients With Shock

NCT07373717 · tracked via the Priya Life Science China tracker
Sponsor
Southeast University, China
Phase
Started
2025-11-02
Last updated
2026-01-28

Condition(s) studied

Shock

Study summary

This study aims to explore the feasibility and scientific validity of carotid-jugular Doppler in evaluating volume tolerance in shock patients (with the VExUS score as an important reference standard), and to conduct an in-depth analysis of the correlation between its monitoring indicators and patient prognosis.The primary endpoint is comparison of the agreement between hands-free carotid-jugular Doppler and the VExUS score in evaluating volume tolerance.The secondary endpoint is correlation between volume tolerance assessed by hands-free carotid-jugular Doppler and the clinical outcomes of shock patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Shock patients admitted to the ICU are defined as those with persistent hypotension (systolic blood pressure \< 90 mmHg or a decrease of ≥ 40 mmHg from the baseline blood pressure) accompanied by signs of tissue hypoperfusion. * Age ≥ 18 years old. * The patient or their legal representatives signed the informed consent form. Exclusion Criteria: * Patients with severe pulmonary circulatory disorders such as severe pulmonary hypertension and acute pulmonary embolism. * Patients with right ventricular myocardial infarction or severe tricuspid regurgitation. * Patients with severe neck trauma or deformity that affects Doppler examination of cervical arteries and veins, or those with anatomical contraindications preventing evaluation of at least one cervical artery or vein. * Pregnant or lactating women. * Patients with diseases that may interfere with abdominal ultrasound examination.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Zhongda Hospital Affiliated to Southeast University Nanjing Jiangsu
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07373717 on ClinicalTrials.gov ↗ ← All trials in China